Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against <i>Borrelia burgdorferi</i> In Vitro and In Vivo
Lyme disease caused by the <i>Borrelia burgdorferi</i> (<i>Bb or B. burgdorferi</i>) is the most common vector-borne, multi-systemic disease in the USA. Although most Lyme disease patients can be cured with a course of the first line of antibiotic treatment, some patients are...
Main Authors: | Hari-Hara S. K. Potula, Jahanbanoo Shahryari, Mohammed Inayathullah, Andrey Victorovich Malkovskiy, Kwang-Min Kim, Jayakumar Rajadas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/9/633 |
Similar Items
-
Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary Phase <em>Borrelia burgdorferi</em>
by: Hector S. Alvarez-Manzo, et al.
Published: (2020-08-01) -
FACTORS RESPONSIBLE FOR THE DEVELOPMENT OF LYME CARDITIS
by: Tomasz Chmielewski, et al.
Published: (2017-04-01) -
Disulfiram—Mitigating Unintended Effects
by: Martha M. Grout, et al.
Published: (2023-01-01) -
First case report of inducible heart block in Lyme disease and an update of Lyme carditis
by: Don Walter Kannangara, et al.
Published: (2019-05-01) -
Lyme Carditis: From Pathophysiology to Clinical Management
by: Cinzia Radesich, et al.
Published: (2022-05-01)